Similar articles for PMID: 29759967

Year	Number of Results
1948	1
1970	1
1990	1
1991	1
1992	1
1994	4
1995	1
1996	2
1997	2
1998	6
1999	4
2003	3
2005	7
2006	8
2007	3
2008	5
2009	1
2010	1
2011	3
2012	3
2013	6
2014	4
2015	5
2016	2
2018	5
2019	4
2020	1
2021	3
2022	2

1

Cytisine for smoking cessation.

Karnieg T, Wang X. Karnieg T, et al. CMAJ. 2018 May 14;190(19):E596. doi: 10.1503/cmaj.171371. CMAJ. 2018. PMID: 29759967 Free PMC article. No abstract available.

2

Cytisine, the world's oldest smoking cessation aid.

Prochaska JJ, Das S, Benowitz NL. Prochaska JJ, et al. BMJ. 2013 Aug 23;347:f5198. doi: 10.1136/bmj.f5198. BMJ. 2013. PMID: 23974638 No abstract available.

3

What is the clinical effectiveness and cost-effectiveness of cytisine compared with varenicline for smoking cessation? A systematic review and economic evaluation.

Leaviss J, Sullivan W, Ren S, Everson-Hock E, Stevenson M, Stevens JW, Strong M, Cantrell A. Leaviss J, et al. Health Technol Assess. 2014 May;18(33):1-120. doi: 10.3310/hta18330. Health Technol Assess. 2014. PMID: 24831822 Free PMC article. Review.

4

The effectiveness of Cytisine versus Nicotine Replacement Treatment for smoking cessation in the Russian Federation.

Castaldelli-Maia JM, Martins SS, Walker N. Castaldelli-Maia JM, et al. Int J Drug Policy. 2018 Aug;58:121-125. doi: 10.1016/j.drugpo.2018.05.012. Epub 2018 Jun 18. Int J Drug Policy. 2018. PMID: 29929154 No abstract available.

5

The effectiveness, safety and cost-effectiveness of cytisine versus varenicline for smoking cessation in an Australian population: a study protocol for a randomized controlled non-inferiority trial.

Thomas D, Farrell M, McRobbie H, Tutka P, Petrie D, West R, Siahpush M, Gartner C, Walker N, Mendelsohn CP, Hall W, Paul C, Zwar N, Ferguson SG, Boland VC, Richmond R, Doran CM, Shakeshaft A, Mattick RP, Courtney RJ. Thomas D, et al. Addiction. 2019 May;114(5):923-933. doi: 10.1111/add.14541. Epub 2019 Feb 3. Addiction. 2019. PMID: 30589984 Clinical Trial.

6

Cytisine for nicotine addiction treatment: a review of pharmacology, therapeutics and an update of clinical trial evidence for smoking cessation.

Tutka P, Vinnikov D, Courtney RJ, Benowitz NL. Tutka P, et al. Addiction. 2019 Nov;114(11):1951-1969. doi: 10.1111/add.14721. Epub 2019 Jul 19. Addiction. 2019. PMID: 31240783 Review.

7

Nicotinic receptor partial agonists as novel compounds for the treatment of smoking cessation.

Tutka P. Tutka P. Expert Opin Investig Drugs. 2008 Oct;17(10):1473-85. doi: 10.1517/13543784.17.10.1473. Expert Opin Investig Drugs. 2008. PMID: 18808308 Review.

8

Cytisine--a tobacco treatment hiding in plain sight.

Rigotti NA. Rigotti NA. N Engl J Med. 2014 Dec 18;371(25):2429-30. doi: 10.1056/NEJMe1412313. N Engl J Med. 2014. PMID: 25517710 No abstract available.

9

Efficacy of interventions to combat tobacco addiction: Cochrane update of 2012 reviews.

Hartmann-Boyce J, Stead LF, Cahill K, Lancaster T. Hartmann-Boyce J, et al. Addiction. 2013 Oct;108(10):1711-21. doi: 10.1111/add.12291. Epub 2013 Aug 14. Addiction. 2013. PMID: 23834141

10

Cytisine for smoking cessation: a research agenda.

Etter JF, Lukas RJ, Benowitz NL, West R, Dresler CM. Etter JF, et al. Drug Alcohol Depend. 2008 Jan 1;92(1-3):3-8. doi: 10.1016/j.drugalcdep.2007.06.017. Epub 2007 Sep 6. Drug Alcohol Depend. 2008. PMID: 17825502 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed